4.6 Article

Prevalence of Age-related Macular Degeneration in Elderly Caucasians: The Tromso Eye Study

Journal

OPHTHALMOLOGY
Volume 119, Issue 9, Pages 1737-1743

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ophtha.2012.03.016

Keywords

-

Categories

Funding

  1. Northern Norway Regional Health Authority [SFP897-09]

Ask authors/readers for more resources

Purpose: To describe the sex- and age-specific prevalence of drusen, geographic atrophy, and neovascular age-related macular degeneration (AMD). Design: Population-based, cross-sectional study. Participants: Caucasian adults aged 65 to 87 years from the 6th Tromso Study, a population-based study conducted in 2007-2008 in the municipality of Tromso, Norway. Methods: Digital color fundus photographs were graded for predominant phenotype based on drusen size, geographic atrophy, and neovascular AMD. Main Outcome Measures: Age-related macular degeneration. Results: A total of 3025 subjects participated; 89% of those were invited to the eye examinations. Gradable photographs were available for 2631 persons (mean age 72.3 years). Drusen 63-125 mu m as the predominant phenotype were found in 34.9% of participants (95% confidence interval [CI], 33.1-36.8), drusen > 125 mu m were found in 24.1% (95% CI, 22.5-25.8), geographic atrophy was found in 1.0% of participants (95% CI, 0.6 - 1.4), and neovascular AMD was found in 2.5% of participants (95% CI, 1.9 -3.1). Bilateral involvement of late AMD was present in 1.1% of the sample. Eyes with late AMD had a significantly lower refractive error (spherical equivalent 0.078 vs. 0.99 diopters, P<0.0001), and 42.5% of eyes had Snellen visual acuity <= 0.32. Conclusions: The prevalence of AMD among the elderly persons in this study was similar to rates in other Caucasian populations. Late AMD was present in 10.9% of subjects aged 80 years or more. No sex differences in prevalence rates of large drusen or late AMD were observed. Lower refractive error was observed in eyes with late AMD than in eyes without late AMD. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article. Ophthalmology 2012;119:1737-1743 (c) 2012 by the American Academy of Ophthalmology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available